Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200321736> ?p ?o ?g. }
- W4200321736 abstract "Impressive clinical benefit is seen in clinic with PD-1 inhibitors on portion of cancer patients. Yet, there remains an urgent need to develop effective synergizers to expand their clinical application. Tumor-associated macrophage (TAM), a type of M2-polarized macrophage, eliminates or suppresses T-cell-mediated anti-tumor responses. Transforming TAMs into M1 macrophages is an attractive strategy of anti-tumor therapy. Here, we conducted a high-throughput screening and found that Carfilzomib potently drove M2 macrophages to express M1 cytokines, phagocytose tumor cells, and present antigens to T cells. Mechanistically, Carfilzomib elicited unfolded protein response (UPR), activated IRE1α to recruit TRAF2, and activated NF-κB to transcribe genes encoding M1 markers in M2 macrophages. In vivo, Carfilzomib effectively rewired tumor microenvironment through reprogramming TAMs into M1-like macrophages and shrank autochthonous lung cancers in transgenic mouse model. More importantly, Carfilzomib synergized with PD-1 antibody to almost completely regress autochthonous lung cancers. Given the safety profiles of Carfilzomib in clinic, our work suggested a potentially immediate application of combinational treatment with Carfilzomib and PD-1 inhibitors for patients with solid tumors." @default.
- W4200321736 created "2021-12-31" @default.
- W4200321736 creator A5000374825 @default.
- W4200321736 creator A5006704370 @default.
- W4200321736 creator A5011487190 @default.
- W4200321736 creator A5012098339 @default.
- W4200321736 creator A5015648408 @default.
- W4200321736 creator A5016470561 @default.
- W4200321736 creator A5026513735 @default.
- W4200321736 creator A5045601651 @default.
- W4200321736 creator A5053712480 @default.
- W4200321736 creator A5058405672 @default.
- W4200321736 creator A5058738211 @default.
- W4200321736 creator A5060596609 @default.
- W4200321736 creator A5067417882 @default.
- W4200321736 creator A5069827895 @default.
- W4200321736 creator A5074677867 @default.
- W4200321736 creator A5076472783 @default.
- W4200321736 creator A5078944760 @default.
- W4200321736 date "2021-12-13" @default.
- W4200321736 modified "2023-10-09" @default.
- W4200321736 title "Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer" @default.
- W4200321736 cites W1548506283 @default.
- W4200321736 cites W1926376253 @default.
- W4200321736 cites W1971620413 @default.
- W4200321736 cites W1980485314 @default.
- W4200321736 cites W1988702078 @default.
- W4200321736 cites W2001790670 @default.
- W4200321736 cites W2016742872 @default.
- W4200321736 cites W2026642838 @default.
- W4200321736 cites W2042029019 @default.
- W4200321736 cites W2055620105 @default.
- W4200321736 cites W2058648826 @default.
- W4200321736 cites W2074061180 @default.
- W4200321736 cites W2076272449 @default.
- W4200321736 cites W2076743146 @default.
- W4200321736 cites W2084802884 @default.
- W4200321736 cites W2093705034 @default.
- W4200321736 cites W2103634965 @default.
- W4200321736 cites W2108929503 @default.
- W4200321736 cites W2118636735 @default.
- W4200321736 cites W2122398369 @default.
- W4200321736 cites W2128444087 @default.
- W4200321736 cites W2131130971 @default.
- W4200321736 cites W2133963438 @default.
- W4200321736 cites W2137967850 @default.
- W4200321736 cites W2147950253 @default.
- W4200321736 cites W2150678612 @default.
- W4200321736 cites W2155712529 @default.
- W4200321736 cites W2158813742 @default.
- W4200321736 cites W2162695817 @default.
- W4200321736 cites W2274241277 @default.
- W4200321736 cites W2294356527 @default.
- W4200321736 cites W2316027242 @default.
- W4200321736 cites W2520601585 @default.
- W4200321736 cites W2582686270 @default.
- W4200321736 cites W2591627715 @default.
- W4200321736 cites W2601621622 @default.
- W4200321736 cites W2766746427 @default.
- W4200321736 cites W2768315100 @default.
- W4200321736 cites W2884673843 @default.
- W4200321736 cites W2890365959 @default.
- W4200321736 cites W2892171609 @default.
- W4200321736 cites W2903708756 @default.
- W4200321736 cites W2918546246 @default.
- W4200321736 cites W2921622709 @default.
- W4200321736 cites W2922202142 @default.
- W4200321736 cites W2945777288 @default.
- W4200321736 cites W2972291002 @default.
- W4200321736 cites W3024548330 @default.
- W4200321736 cites W3045946240 @default.
- W4200321736 cites W3118934078 @default.
- W4200321736 cites W3128859299 @default.
- W4200321736 cites W4312314171 @default.
- W4200321736 doi "https://doi.org/10.15252/emmm.202114502" @default.
- W4200321736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34898004" @default.
- W4200321736 hasPublicationYear "2021" @default.
- W4200321736 type Work @default.
- W4200321736 citedByCount "18" @default.
- W4200321736 countsByYear W42003217362022 @default.
- W4200321736 countsByYear W42003217362023 @default.
- W4200321736 crossrefType "journal-article" @default.
- W4200321736 hasAuthorship W4200321736A5000374825 @default.
- W4200321736 hasAuthorship W4200321736A5006704370 @default.
- W4200321736 hasAuthorship W4200321736A5011487190 @default.
- W4200321736 hasAuthorship W4200321736A5012098339 @default.
- W4200321736 hasAuthorship W4200321736A5015648408 @default.
- W4200321736 hasAuthorship W4200321736A5016470561 @default.
- W4200321736 hasAuthorship W4200321736A5026513735 @default.
- W4200321736 hasAuthorship W4200321736A5045601651 @default.
- W4200321736 hasAuthorship W4200321736A5053712480 @default.
- W4200321736 hasAuthorship W4200321736A5058405672 @default.
- W4200321736 hasAuthorship W4200321736A5058738211 @default.
- W4200321736 hasAuthorship W4200321736A5060596609 @default.
- W4200321736 hasAuthorship W4200321736A5067417882 @default.
- W4200321736 hasAuthorship W4200321736A5069827895 @default.
- W4200321736 hasAuthorship W4200321736A5074677867 @default.
- W4200321736 hasAuthorship W4200321736A5076472783 @default.
- W4200321736 hasAuthorship W4200321736A5078944760 @default.
- W4200321736 hasBestOaLocation W42003217361 @default.